Journal
GLIA
Volume 34, Issue 2, Pages 73-80Publisher
WILEY
DOI: 10.1002/glia.1042
Keywords
Parkinson's disease; reactive oxygen species; dopamine; cell culture
Categories
Funding
- NCI NIH HHS [CA21765] Funding Source: Medline
- NIEHS NIH HHS [ES10772] Funding Source: Medline
- NINDS NIH HHS [NS39006] Funding Source: Medline
Ask authors/readers for more resources
Parkinson's disease (PD) is a debilitating neurological disorder that strikes approximately 2% of people over age 50. Current hypotheses propose that the cause of PD is multifactorial, involving environmental agents and genetic predisposition. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces parkinsonism in many species, including humans and shows strain specificity in mice. The mechanism of strain specificity, however, remains unknown. Using novel chimeric murine substantia nigra cultures, we demonstrate that sensitivity to MPTP is conferred by glia and that it does not involve the MAO-B conversion of MPTP to MPP+. C57Bl/6J dopaminergic neurons exposed to MPP+ demonstrated a 39% loss when cultured on C57Bl/6J glia compared with 17% neuron loss when cultured on resistant SWR/J glia. Similarly, SWR/J neurons exposed to MPP+ demonstrated a 4% loss when cultured on SWR/J glia, but a 14% loss when cultured on sensitive C57Bl/6J glia. The identification of glia as the critical cell type in the genesis of experimental Parkinsonism provides a target for the development of new anti-parkinsonian therapies. GLIA 34:73-80, 2001. (C) 2001 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available